Our team is made up of home brewers, thinkers, innovators, farmers, scientists, problem solvers, and business development leaders. These traits of the Xylogenics team are intensely focused on delivering product innovations that are safe, scaleable, and highly valuable to bio-based chemical producers.
Josh is one of the inventors of GX-1 and co-founders of Xylogenics. He received his Ph.D. in yeast biochemistry in 2010 after starting Xylogenics. He has extensive ethanol plant trialing experience where he has built a reputation for his integrity and knowledge. Josh also spearheaded the initial commercial development of GX-1, guiding the team to successfully enable independent development and commercialization of Xylogenics technologies.
Mark is a Professor of Biochemistry and Molecular Biology in the Indiana University School of Medicine. He is a Founder and Chief Scientific Advisor of Xylogenics. He received his Ph.D. from the University of Chicago in the Department of Molecular Genetics and Cell Biology and did post-doctoral work in the Department of Genetics of the University of Washington (Seattle). Dr. Goebl has over 25 years of experience in yeast biology.
Matt currently serves as the Chief Scientific Officer. Matt’s oversees operations of Xylogenics analytical laboratory and to interfaces with ethanol plants in order to optimize our laboratory models for plant scale operations. His core duties involve smooth scale-up transitions and analytical support to plant managers and efficient communications with Xylogenics leadership.
Ross is working alongside Dr. Goebl spearheading the annotation of our newly acquired commercial yeast sequence data. He is also conducting a GX-1 gene profiling study to help Xylogenics better understand yeasts response to industrial fermentations. This information will be used to guide further enhancement of our strains. Under Dr. Craig Pikaard at IU he learned to manage and annotate next generation sequence data. Ross holds a Ph.D. in Biochemistry and Molecular Biology from the Indiana University School of Medicine.
Nadaraj is currently working on the design and strategy for delivering a GX-1 cellulosic strain for corn fiber fermentation. This strategy will lead to a huge opportunity for our technology in the emerging cellulosic ethanol market. He has 15 years of molecular microbiological experience in research and development of microbial natural products for application in pharmaceutical and agricultural industries.
Katie now serves as the VP of Operations for Xylogenics, having previously run the Xylogenics laboratory. Prior to Xylogenics she worked under Dr. Radcliffe at Purdue University to study the nutrition of non-ruminant animals, specifically relating to DDGS metabolism. She has been part of the Xylogenics team since completing her Bachelors in 2010. She has a Bachelor of Science in biology from Purdue University and an MBA from the Indiana University Kelley School of Business.